We are live on ! Find out more
ATRA icon

Atara Biotherapeutics

121 hedge funds and large institutions have $1.68B invested in Atara Biotherapeutics in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $4.58M | Put options by funds: $1.5M

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

5% more funds holding

Funds holding: 115121 (+6)

5% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 39

0.14% more ownership

Funds ownership: 4.09%4.23% (+0.14%)

13% less capital invested

Capital invested by funds: $1.92B → $1.68B (-$240M)

Holders
121
Holders Change
+6
Holders Change %
+5.22%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
20
Increased
41
Reduced
39
Closed
13
Calls
$4.58M
Puts
$1.5M
Net Calls
+$3.08M
Net Calls Change
+$4.51M